The PrescriberPub Date : 2023-07-01DOI: 10.1002/psb.2080
S. Titmarsh
{"title":"Best Practice London: focus on lipid and migraine management","authors":"S. Titmarsh","doi":"10.1002/psb.2080","DOIUrl":"https://doi.org/10.1002/psb.2080","url":null,"abstract":"Lipid‐lowering therapy to prevent cardiovascular disease and practical aspects of migraine management were among the topics presented at continuing professional development sessions during the Best Practice London conference held in March 2023. Steve Titmarsh reports.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86064222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The PrescriberPub Date : 2023-07-01DOI: 10.1002/psb.2079
G. Parsons
{"title":"Understanding liver function tests: part 1","authors":"G. Parsons","doi":"10.1002/psb.2079","DOIUrl":"https://doi.org/10.1002/psb.2079","url":null,"abstract":"Liver function tests (LFTs) are useful blood tests to help identify liver disease, but their interpretation can be challenging. Part 1 in this two‐part series on understanding LFTs discusses who should be screened, the advantages and limitations of the main LFTs, and how LFTs should be interpreted.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"82 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73398789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The PrescriberPub Date : 2023-07-01DOI: 10.1002/psb.2078
M. Greener
{"title":"Is the NHS ready for new Alzheimer's disease treatments?","authors":"M. Greener","doi":"10.1002/psb.2078","DOIUrl":"https://doi.org/10.1002/psb.2078","url":null,"abstract":"New effective treatments for Alzheimer's disease have eluded researchers for many years, but promising pharmacotherapies may at last be approaching clinical approval. This article examines some of these new treatments, their modes of action and the practicalities of implementation once they reach the market.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81326120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The PrescriberPub Date : 2023-07-01DOI: 10.1002/psb.2081
S. Chaplin
{"title":"Tirzepatide for the treatment of adults with type 2 diabetes","authors":"S. Chaplin","doi":"10.1002/psb.2081","DOIUrl":"https://doi.org/10.1002/psb.2081","url":null,"abstract":"Tirzepatide (Mounjaro) is a dual GLP‐1/GIP receptor agonist for the treatment of type 2 diabetes in adults. This article discusses its administration, clinical trial efficacy and adverse effects.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"308 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85717957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The PrescriberPub Date : 2023-07-01DOI: 10.1002/psb.2077
Aisling Molloy
{"title":"MAOI prescribing: separating misconceptions from reality","authors":"Aisling Molloy","doi":"10.1002/psb.2077","DOIUrl":"https://doi.org/10.1002/psb.2077","url":null,"abstract":"Monoamine oxidase inhibitors (MAOIs) are generally only initiated by specialists because of safety concerns, making GPs more wary of these medicines. This article discusses the important side‐effects and interactions of MAOIs and how these can be minimised, and explains why MAOI prescribing may be safer than we are led to believe.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73282457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The PrescriberPub Date : 2023-07-01DOI: 10.1002/psb.2082
S. Chaplin
{"title":"Diagnosis and management of type 2 diabetes in children","authors":"S. Chaplin","doi":"10.1002/psb.2082","DOIUrl":"https://doi.org/10.1002/psb.2082","url":null,"abstract":"NICE has recently updated its guideline on the management of diabetes in children and young people (NG18), with new recommendations on monitoring and treating type 2 diabetes in young patients. This article summarises the main changes in the latest update.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"117 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77039808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The PrescriberPub Date : 2023-06-01DOI: 10.1002/psb.2070
M. Greener
{"title":"Update on chronotherapy: it's about time","authors":"M. Greener","doi":"10.1002/psb.2070","DOIUrl":"https://doi.org/10.1002/psb.2070","url":null,"abstract":"Chronotherapy is a promising approach to drug dosing that optimises the timing of administration to synchronise with our circadian rhythms. This article discusses how researchers are finding ways to utilise chronotherapy's potential to increase the efficacy and safety of various drug therapies.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87879730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
求助内容：
应助结果提醒方式：